Skip to main content

Advertisement

SpringerLink
Log in

Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Franz CC, Egger S, Born C, Bravo AER, Krähenbühl S (2012) Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol 68:179–188

    Article  CAS  Google Scholar 

  2. Verbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64:1147–1161

    Article  CAS  Google Scholar 

  3. Laffi G, Daskalopoulos G, Kronborg I, Hsueh W, Gentilini P, Zipser RD (1986) Effects of sulindac and ibuprofen in patients with cirrhosis and ascites: an explanation for the renal-sparing effect of sulindac. Gastroenterology 90:182–187

    Article  CAS  Google Scholar 

  4. Hawcutt DB, Russell N, Maqsood H, Kouranloo K, Gomberg S, Waitt C, Sharp A, Riordan A, Turner MA (2016) Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001–2010: content and utility analysis. Br J Clin Pharmacol 82:1601–1612

    Article  Google Scholar 

  5. Carnovale C, Gentili M, Fortino I, Merlino L, Clementi E, Radice S, on behalf the ViGer Group (2016) The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme. Expert Opin Drug Saf 15:131–139

    Article  CAS  Google Scholar 

  6. Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R (2015) Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Hepatology 62:1620–1622

    Article  Google Scholar 

  7. Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, Taxis K, Borgsteede SD (2018) Evidence-based recommendations to improve the safe use of drugs in patients with liver cirrhosis. Drug Saf 41:603–613

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Unit of Pharmacotherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands

    R. A. Weersink, K. Taxis & E. P. van Puijenbroek

  2. Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands

    R. A. Weersink & S. D. Borgsteede

  3. Pharmacovigilance Center Lareb, ‘s-Hertogenbosch, The Netherlands

    E. P. van Puijenbroek

  4. Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands

    S. D. Borgsteede

Authors
  1. R. A. Weersink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Taxis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. P. van Puijenbroek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. D. Borgsteede
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. A. Weersink.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weersink, R.A., Taxis, K., van Puijenbroek, E.P. et al. Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports. Eur J Clin Pharmacol 76, 741–743 (2020). https://doi.org/10.1007/s00228-020-02845-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-020-02845-9

Search

Navigation